Ilkka Kantola
 Professor; Head of Medical Division, Turku university Hospital

Docent,  Faculty of Medicine (University of Turku) ilkkan@utu.fi : https://orcid.org/0000-0002-6228-522X CURRICULUM VITAE OF ILKKA KANTOLA041117.pdf

  

  

  

7 of 10

  

  

  

---

• ECG left ventricular hypertrophy is a stronger risk factor for incident cardiovascular events in women than in men in the general population  (2015)  
  • Journal of Hypertension
   Porthan K, Niiranen TJ, Varis J, Kantola I, Karanko H, Kähönen M, Nieminen MS, Salomaa V, Huikuri HV, Jula AM

  
  

• Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial  (2015)  
  • JAMA Dermatology
   George L. Bakris, Rajiv Agarwal, Juliana C. Chan, Mark E. Cooper, MD, Ron T. Gansevoort, Hermann Haller, Giuseppe Remuzzi, Peter Rossing, Roland E. Schmieder, Christina Nowack, Peter Kolkhof, Amer Joseph, Alexander Pieper, Nina Kimmeskamp-Kirschbaum, Luis M. Ruilope ; for the Mineralocorticoid Receptor Antagonist Tolerability Study–Diabetic Nephropathy (ARTS-DN) Study Group

  
  

• Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes  (2015)  
  • New England Journal of Medicine
   Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J, Josse R, Kaufman KD, Koglin J, Korn S, Lachin JM, McGuire DK, Pencina MJ, Standl E, Stein PP, Suryawanshi S, Van de Werf F, Peterson ED, Holman RR; for the TECOS Study Group

  
  

• Evaluation of the efficacy and safety of three dosing regimens of agalsidase alfa enzyme replacement therapy in adults with Fabry disease  (2015)  
  • Drug Design, Development and Therapy
   Goláň L, Goker-Alpan O, Holida M, Kantola I, Klopotowski M, Kuusisto J, Linhart A, Musial J, Nicholls K, Gonzalez-Rodriguez D, Sharma R, Vujkovac B, Chang P, Wijatyk A

  
  

• Factors modifying the effect of blood pressure on erectile function  (2015)  
  • Journal of Hypertension
   Korhonen PE, Ettala O, Kautiainen H, Kantola I

  
  

• High blood pressure and its variation and the use of beta blocking agents and statins decrease quality of life in drug-treated hypertensive patients  (2015)  
  • Journal of Hypertension
   Kantola I1, Merikari M, Tervo J, Koskio L, Haijanen J, Hermansson H, Kantola T, Mäkelä P, Rehunen S, Varis J

  
  

• High prevalence of chronic kidney disease in Finnish patients with type 2 diabetes treated in primary care  (2015)  
  • Primary Care Diabetes
   Metsarinne K, Broijersen A, Kantola I, Niskanen L, Rissanen A, Appelroth T, Pontynen N, Poussa T, Koivisto V, Virkamaki A; for the STONE (STages of NEphropathy in type 2 diabetes) study investigators

  
  

• Individual patient data meta-analysis of self-monitoring of blood pressure (BP-SMART): a protocol  (2015)  
  • BMJ Open
   Tucker KL, Sheppard JP, Stevens R, Bosworth HB, Bove A, Bray EP, Godwin M, Green B, Hebert P, Hobbs FDR, Kantola I, Kerry S, Magid DJ, Mant J, Margolis KL, McKinstry B, Omboni S, Ogedegbe O, Parati G, Qamar N, Varis J, Verberk W, Wakefield BJ, McManus RJ

  
  

• Patients with resistant hypertension have more peripheral arterial disease than other uncontrolled hypertensives  (2015)  
  • Journal of Human Hypertension
   Korhonen PE, Kautiainen H, Kantola I

  
  

• Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document  (2015)  
  • Orphanet Journal of Rare Diseases
   Biegstraaten M, Arngrímsson R, Barbey F, Boks L, Cecchi F, Deegan PB, Feldt-Rasmussen U, Geberhiwot T, Germain DP, Hendriksz C, Hughes DA, Kantola I Karabul N, Lavery C, Linthorst GE, Mehta A, van de Mheen E, Oliveira JP, Parini R, Ramaswami U, Rudnicki M, Serra A, Sommer C, Sunder-Plassmann G, Svarstad E, Sweeb A, Terryn W, Tylki-Szymanska A, Tøndel C, Vujkovac B, Weidemann F, Wijburg FA, Woolfson P, Hollak CE